HLA class II expression in human tumor lines.
Blanck
G
G
Department of Biochemistry and Molecular Biology, College of Medicine, Immunology Program, Moffitt Cancer Center, University of South Florida, Tampa, Florida 33612, USA.
D015972:Gene Expression Regulation, Neoplastic; D005802:Genes, MHC Class II / Q000235:genetics* / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009687:Nuclear Proteins; D016160:Retinoblastoma Protein / Q000502:physiology; D015534:Trans-Activators / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured
D000949:Histocompatibility Antigens Class II; C083728:MHC class II transactivator protein; D009687:Nuclear Proteins; D016160:Retinoblastoma Protein; D015534:Trans-Activators